Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Signaling pathway involving release and caspase 3 activation is conserved
this agent is a recombinant form of the IL-1R antagonist (IL-1Ra) that competitively inhibits the binding of IL-1 and IL-1 to the IL-1R1, thus blocking IL-1 signaling and mitigating its inflammatory effects ( The FDA Adverse Event Reporting System (FAERS) database, which gathers spontaneous AE reports from healthcare professionals, pharmaceutical manufacturers, patients, and others from diverse regions, is an invaluable resource for post-market surveillance and the early detection of drug safety issues ( 2 Materials and methods 2.1 Data sources The FAERS database has been publicly available since 2004
These technical specifications make sure that the performance is the same in all formulation environments
This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition
US$ 24.61
US$ 26.92
US$ 25.07
US$ 29.48
US$ 21.69
US$ 29.28
US$ 22.81
US$ 23.67
US$ 22.20
